These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 2558549)
1. Potent and specific inhibitors of mammalian phosphoribosylpyrophosphate (PRPP) synthetase. Willis RC; Nord LD; Fujitaki JM; Breen TS; Matsumoto SS Adv Exp Med Biol; 1989; 253B():7-12. PubMed ID: 2558549 [No Abstract] [Full Text] [Related]
2. PRPP and purine nucleotide metabolism in human lymphoblasts with both PRPP synthetase superactivity and HGPRT deficiency. Becker MA; Kim M; Husain K Adv Exp Med Biol; 1989; 253B():13-20. PubMed ID: 2481968 [No Abstract] [Full Text] [Related]
3. Methylmercaptopurine ribonucleoside toxicity in human fibroblasts: inhibition of phosphoribosylpyrophosphate synthetase as well as amidophosphoribosyltransferase. Yen RC; Becker MA Adv Exp Med Biol; 1979; 122B():137-43. PubMed ID: 232627 [No Abstract] [Full Text] [Related]
4. Inhibition of phosphoribosylpyrophosphate synthesis in human fibroblasts by 6-methylthioinosinate. Yen RC; Raivio KO; Becker MA J Biol Chem; 1981 Feb; 256(4):1839-45. PubMed ID: 6257688 [No Abstract] [Full Text] [Related]
5. Inhibition of phosphoribosylpyrophosphate synthetase by 4-methoxy-(MRPP) and 4-amino-8-(D-ribofuranosylamino) pyrimido[5,4-d]pyrimidine (ARPP). Nord LD; Willis RC; Breen TS; Avery TL; Finch RA; Sanghvi YS; Revankar GR; Robins RK Biochem Pharmacol; 1989 Oct; 38(20):3543-9. PubMed ID: 2479382 [TBL] [Abstract][Full Text] [Related]
6. Regulation of purine nucleotide synthesis in human B lymphoblasts with both hypoxanthine-guanine phosphoribosyltransferase deficiency and phosphoribosylpyrophosphate synthetase superactivity. Becker MA; Kim M; Husain K; Kang T J Biol Chem; 1992 Mar; 267(7):4317-21. PubMed ID: 1311306 [TBL] [Abstract][Full Text] [Related]
7. Pyrimidine nucleotides impair phosphoribosylpyrophosphate (PRPP) synthetase subunit aggregation by sequestering magnesium. A mechanism for the decreased PRPP synthetase activity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency. Lachant NA; Zerez CR; Tanaka KR Biochim Biophys Acta; 1989 Jan; 994(1):81-8. PubMed ID: 2535789 [TBL] [Abstract][Full Text] [Related]
8. Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts. Zoref E; De Vries A; Sperling O J Clin Invest; 1975 Nov; 56(5):1093-9. PubMed ID: 171280 [TBL] [Abstract][Full Text] [Related]
9. Regulation of phosphoribosylpyrophosphate synthetase by endogenous purine and pyrimidine compounds and synthetic analogs in normal and leukemic white blood cells. Danks MK; Scholar EM Biochem Pharmacol; 1982 May; 31(9):1687-91. PubMed ID: 6285931 [TBL] [Abstract][Full Text] [Related]
11. Potent and specific inhibitors of mammalian phosphoribosylpyrophosphate (PRPP) synthetase. Willis RC; Nord LD; Fujitaki JM; Robins RK Adv Enzyme Regul; 1989; 28():167-82. PubMed ID: 2560324 [TBL] [Abstract][Full Text] [Related]
12. Increased purine nucleotide degradation in the central nervous system (CNS) in PRPP synthetase superactivity. Jiménez ML; Puig JG; Mateos FA; Ramos TH; Melián JS; Nieto VG; Becker MA Adv Exp Med Biol; 1989; 253A():9-13. PubMed ID: 2560341 [No Abstract] [Full Text] [Related]
13. Biochemical pharmacology and antitumor properties of 4-amino-8-[beta-D-ribofuranosylamino]pyrimido-[5,4-d]pyrimidine. Jackson RC; Boritzki TJ; Cook PD; Hook KE; Leopold WR; Fry DW Adv Enzyme Regul; 1989; 28():185-99. PubMed ID: 2560325 [TBL] [Abstract][Full Text] [Related]
14. Inherited phosphoribosylpyrophosphate synthetase superactivity due to aberrant inhibitor and activator responsiveness. Becker MA; Losman MJ; Simmonds HA Adv Exp Med Biol; 1986; 195 Pt A():59-66. PubMed ID: 3014841 [No Abstract] [Full Text] [Related]
15. Consequences of inhibition of purine biosynthesis de novo by 6-methylmercaptopurine ribonucleoside in cultured lymphoma L5178Y cells. Woods RA; Henderson RM; Henderson JF Eur J Cancer (1965); 1978 Jul; 14(7):765-70. PubMed ID: 658102 [No Abstract] [Full Text] [Related]
16. Inhibition of 5-phosphoribosyl-1-pyrophosphate synthetase by the monophosphate metabolite of 4-amino-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine: a novel mechanism for antitumor activity. Fry DW; Boritzki TJ; Jackson RC; Cook PD; Leopold WR Mol Pharmacol; 1993 Aug; 44(2):479-85. PubMed ID: 7689145 [TBL] [Abstract][Full Text] [Related]
18. Phosphoribosylpyrophosphate synthetase superactivity. A study of five patients with catalytic defects in the enzyme. Becker MA; Losman MJ; Rosenberg AL; Mehlman I; Levinson DJ; Holmes EW Arthritis Rheum; 1986 Jul; 29(7):880-8. PubMed ID: 3017368 [TBL] [Abstract][Full Text] [Related]
19. NAD synthesis by erythrocytes in phosphoribosylpyrophosphate synthetase (PRPPs) superactivity. Micheli V; Simmonds HA Adv Exp Med Biol; 1989; 253A():1-7. PubMed ID: 2560329 [No Abstract] [Full Text] [Related]
20. Characterization of purine nucleotide metabolism in cultured fibroblasts with deficiency of hypoxanthine-guanine phosphoribosyltransferase and with superactivity of phosphoribosylpyrophosphate synthetase. Zoref-Shani E; Sperling O Enzyme; 1980; 25(6):413-8. PubMed ID: 6258915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]